Home                        
   
Contact

For Patients:

For patients interested in participating in a clinical study, please contact a clinical study site that is currently accepting patients for your type of cancer. Note that not all patients will qualify for the study requirements and enrollment is very limited. AuroLase® Therapy is an investigational medical device and is only available through designated clinical study sites.

 

BACK TO TOP

 

 

For Clinicians:

A brief summary of the enrollment criteria for current clinical studies is available and further details can be found at ClinicalTrials.gov, identifier number NCT00848042. For more information regarding basic research, clinical studies, or other topics regarding AuroLase Therapy, please contact Glenn Goodrich at GGoodrich@Nanospectra.com.

 

BACK TO TOP

 

 

For Investors and Media:

If you wish to receive further information about AuroLase Therapy, please contact Info@Nanospectra.com or 713-842-2720.

 

BACK TO TOP

 

 

For Research Collaborators

If you wish to receive further information about Nanospectra's technology, to discuss possible research collaborations, or the purchase of nanoparticles, please contact Products@Nanospectra.com or 713-842-2720.

 

BACK TO TOP

 

 

For Career Opportunities

Nanospectra does not currently have any openings.

If you wish to submit a resume to the Company for employment consideration, please send a pdf file to Human_Resources@Nanospectra.com.

 

BACK TO TOP